TSHA   $2.0  -0.99% Market Closed After Close 1.93 -3.50%

Taysha Gene Therapies Inc
Total Cash 172.74M
totalCashPerShare 0.843
EBITDA -75.72M
Total Debt 58.30M
quickRatio 5.055
currentRatio 5.222
Total Revenue 12.87M
debtToEquity 53.554
Revenue/Share 0.064
ROA -0.34166
ROE -3.18686
grossProfits
freeCashflow -53.95M
operatingCashflow -75.37M
earningsGrowth
revenueGrowth -0.536
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -19.15378
profitMargins 0.0
enterpriseValue 307.74M
forwardPE -4.809524
floatShares 122.28M
sharesOutstanding 204.94M
sharesShort 20.64M
sharesShortPriorMonth 21.66M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.18%
heldPercentInstitutions 0.78%
Short Ratio help_outline 11.29%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 0.541
Price To Book help_outline 3.73
earningsQuarterlyGrowth
netIncomeToCommon -114.33M
trailingEps -0.49%
forwardEps -0.42%
enterpriseToEbitda -4.06
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.09 3Q 2024
institutionsCount 148
lastUpdated Oct. 22, 2024, 12:17 a.m.